Addiction and MASH: Preclinical studies found GLP-1 signaling in the reward circuits of the brain can reduce addictive behaviors
Trials have shown compelling weight loss, robust reductions in triglycerides, LDL cholesterol, liver fat content, & blood pressure
This exclusion is why many states do not cover weight loss shots through Medicaid, even though the medications are FDA-approved
Thus, it has been proposed that L-carnitine incr urea synth in the liver by facilitating fatty acid entry into mitochondria, leading to incr flux through the beta-oxidation pathway, an incr of intramitochondrial reducing equivalents, and enhancement of ATP production
Table of Contents Introduction Semaglutide is a medication that has gained attention for its role in managing diabetes and promoting weight loss